Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-19-004621
Filing Date
2019-04-01
Accepted
2019-04-01 17:26:21
Documents
49
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 755638
2 logo_001.jpg GRAPHIC 26410
3 ex31-1.htm EX-31.1 18792
4 ex31-2.htm EX-31.2 18495
5 ex32-1.htm EX-32.1 6568
6 ex32-2.htm EX-32.2 6458
  Complete submission text file 0001493152-19-004621.txt   2733755

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE capd-20181231.xml EX-101.INS 314212
8 XBRL SCHEMA FILE capd-20181231.xsd EX-101.SCH 25943
9 XBRL CALCULATION FILE capd-20181231_cal.xml EX-101.CAL 36126
10 XBRL DEFINITION FILE capd-20181231_def.xml EX-101.DEF 105289
11 XBRL LABEL FILE capd-20181231_lab.xml EX-101.LAB 187673
12 XBRL PRESENTATION FILE capd-20181231_pre.xml EX-101.PRE 163618
Mailing Address 20 RAOUL WALLENBERG ST., TEL AVIV, L3 6971916
Business Address 20 RAOUL WALLENBERG ST., TEL AVIV, L3 6971916 972-3-6130421
CANNAPOWDER, INC. (Filer) CIK: 0001086082 (see all company filings)

EIN.: 870626333 | State of Incorp.: UT | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26027 | Film No.: 19721967
SIC: 2834 Pharmaceutical Preparations